Clinical Trial Update: Clinical Study to Assess the Long-term Safety and Tolerability of ACT 064992 in Patients With Symptomatic Pulmonary Arterial Hypertension [Phase 3]

View source ↗

Summary

This clinical trial update reports the completion of a Phase 3 study evaluating the long-term safety and tolerability of ACT 064992 in patients with symptomatic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• ACT 064992

Snippet

Sponsor: Actelion | Conditions: Pulmonary Arterial Hypertension | Phase 3 | Status: COMPLETED | Results posted: 2022-02-10